METHYLATION OF SRD5A2 PROMOTER PREDICTS A BETTER OUTCOME FOR PATIENTS UNDERGOING ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

被引:0
|
作者
Deng, Tuo
Lin, Xueming
Wu, Shulin
Zhang, Zhenwei
Wu, Chin-Lee
Yan, Liying
Taplin, Mary-Ellen
Wang, Zongwei
Olumi, Aria
机构
来源
JOURNAL OF UROLOGY | 2019年 / 201卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP81-16
引用
收藏
页码:E1178 / E1179
页数:2
相关论文
共 50 条
  • [41] Down-regulation of CAMKK2 by androgen deprivation induces castration-resistant prostate cancer
    Mizokami, Atsushi
    Shima, Takashi
    Miyagi, Toru
    Kawai, Keiichi
    Izumi, Kouji
    Kumaki, Misako
    Jian, Zhang
    Keller, Evan T.
    Namiki, Mikio
    CANCER RESEARCH, 2012, 72
  • [42] Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer
    Qin, Jun
    Lee, Hui-Ju
    Wu, San-Pin
    Lin, Shih-Chieh
    Lanz, Rainer B.
    Creighton, Chad J.
    DeMayo, Francesco J.
    Tsai, Sophia Y.
    Tsai, Ming-Jer
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (11): : 5013 - 5026
  • [43] THE EFFECTIVE PERIOD OF FIRST ANDROGEN DEPRIVATION THERAPY BECOMES AN PROGNOSTIC THE EFFECTIVE PERIOD OF FIRST ANDROGEN-DEPRIVATION THERAPY BECOMES AN PROGNOSTIC FACTOR IN DOCETAXEL CHEMOTHERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER PATIENTS
    Shigeta, Keisuke
    Kosaka, Takeo
    MIzuno, Ryuichi
    Shinojima, Toshiaki
    KIkuchi, Eiji
    MIyajima, Akira
    Tanoguchi, Hitoshi
    Hasegawa, Shintaro
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2017, 197 (04): : E714 - E715
  • [44] INVESTIGATING THE IMPACT OF A LOWER TESTOSTERONE THRESHOLD ON CASTRATION-RESISTANT PROGRESSION IN PATIENTS ON CONTINUOUS ANDROGEN DEPRIVATION THERAPY
    Ding, Maylynn
    Lee, Taehyoung
    Di Lena, Richard
    Shayegan, Bobby
    JOURNAL OF UROLOGY, 2019, 201 (04): : E317 - E318
  • [45] Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer
    Lee, Jun Nyung
    Kim, Mi Young
    Kang, Jae Hoon
    Kang, Jun-Koo
    Chung, Jae-Wook
    Ha, Yun-Sok
    Choi, Seock Hwan
    Kim, Bum Soo
    Kim, Hyun Tae
    Kim, Tae-Hwan
    Yoo, Eun Sang
    Kim, See Hyung
    Kwon, Tae Gyun
    INVESTIGATIVE AND CLINICAL UROLOGY, 2024, 65 (02) : 132 - 138
  • [46] Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy
    Oudard, Stephane
    Hadaschik, Boris
    Saad, Fred
    Cella, David
    Basch, Ethan
    Graff, Julie N.
    Uemura, Hiroji
    Dibaj, Shiva
    Li, Susan
    Brookman-May, Sabine D.
    De Porre, Peter
    Bevans, Katherine B.
    Trudeau, Jeremiah J.
    Small, Eric J.
    Smith, Matthew R.
    EUROPEAN UROLOGY FOCUS, 2022, 8 (04): : 958 - 967
  • [47] Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaive patients with metastatic castration-resistant prostate cancer
    Lee, Chung-Lin
    Chang, Ying-Hsu
    Liu, Chung-Yi
    Hsieh, Ming-Li
    Huang, Liang-Kang
    Chu, Yuan-Cheng
    Kan, Hung-Cheng
    Lin, Po-Hung
    Yu, Kai-Jie
    Chuang, Cheng-Keng
    Wu, Chun-Te
    Pang, See-Tong
    Shao, I-Hung
    INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (05) : 546 - 553
  • [48] Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone
    Fan, Liancheng
    Chi, Chenfei
    Guo, Sanwei
    Wang, Yanqing
    Cai, Wen
    Shao, Xiaoguang
    Xu, Fan
    Pan, Jiahua
    Zhu, Yinjie
    Xun Shangguan
    Xin, Zhixiang
    Hu, Jianian
    Qian, Hongyang
    Xie, Shaowei
    Wang, Rui
    Zhou, Lixin
    Dong, Baijun
    Xue, Wei
    JOURNAL OF CANCER, 2017, 8 (17): : 3448 - 3455
  • [49] ANTIOXIDANT THERAPY ALLEVIATES OXIDATIVE STRESS BY ANDROGEN DEPRIVATION AND PREVENTS CONVERSION FROM ANDROGEN-DEPENDENT TO CASTRATION-RESISTANT PROSTATE CANCER
    Shiota, Masaki
    Song, YooHyun
    Takeuchi, Ario
    Yokomizo, Akira
    Kashiwagi, Eiji
    Kuroiwa, Kentaro
    Tatsugami, Katsunori
    Uchiumi, Takeshi
    Oda, Yoshinao
    Naito, Seiji
    JOURNAL OF UROLOGY, 2012, 187 (04): : E318 - E319
  • [50] BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
    Sugawara, Tatsuo
    Lejeune, Pascale
    Koehr, Silke
    Neuhaus, Roland
    Faus, Hortensia
    Gelato, Kathy A.
    Busemann, Matthias
    Cleve, Arwed
    Luecking, Ulrich
    von Nussbaum, Franz
    Brands, Michael
    Mumberg, Dominik
    Jung, Klaus
    Stephan, Carsten
    Haendler, Bernard
    ONCOTARGET, 2016, 7 (05) : 6015 - 6028